5'-UMP disodium salt

Suppliers

Names

[ CAS No. ]:
3387-36-8

[ Name ]:
5'-UMP disodium salt

[Synonym ]:
Disodium Uridine-5-Monophosphate
5'-UMP disodium salt
EINECS 222-211-9
Disodium uridine 5'-phosphate
5'-UMP-NA2
5`-UMP,2Na
5'-UMP 2Na Hydrate
Uridine 5'-Monophosphate Disodium Salt Hydrate
disodiumump
disodium salt of uridine 5'-monophosphate
Disodium 5'-O-phosphonatouridine
MFCD00006525
5'-Uridylic Acid Disodium Salt Hydrate
uridine 5'-monophosphate disodium salt
5′-UMP-Na2
5'-Uridylic acid, sodium salt (1:2)
uridine-5'-monophosphoric acid disodium salt
Uridylic acid disodium salt
uridine-5′-monophosphate disodium
UMP 2NA
5'-Uridylic acid disodium salt
Uridine 5‘-monophosphate,disodium salt,hydrate
Uridine-5'--monophosphate,Disodium salt
UMP,NA2
D-uridine-5'-monophosphate disodium salt
Disodium uridine 5'-monophosphate
UMP DISODIUM

Chemical & Physical Properties

[ Density]:
1.865g/cm3

[ Melting Point ]:
208-210 °C

[ Molecular Formula ]:
C9H11N2Na2O9P

[ Molecular Weight ]:
368.14

[ Exact Mass ]:
367.999756

[ PSA ]:
186.78000

[ Index of Refraction ]:
-14 ° (C=1, H2O)

[ Storage condition ]:
−20°C

[ Water Solubility ]:
40 g/100 mL (20 ºC)

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
YU7975000
CHEMICAL NAME :
Uridine, 5'-dihydrogen phosphate, disodium salt
CAS REGISTRY NUMBER :
3387-36-8
LAST UPDATED :
199712
DATA ITEMS CITED :
6
MOLECULAR FORMULA :
C9-H11-N2-O9-P.2Na
MOLECULAR WEIGHT :
368.17

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>12 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University. (Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143, Japan) V.1- 1954- Volume(issue)/page/year: 22,618,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
3111 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - ataxia Lungs, Thorax, or Respiration - cyanosis
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University. (Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143, Japan) V.1- 1954- Volume(issue)/page/year: 22,618,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>6 gm/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Skin and Appendages - dermatitis, irritative (after systemic exposure)
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University. (Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143, Japan) V.1- 1954- Volume(issue)/page/year: 22,618,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>12 gm/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University. (Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143, Japan) V.1- 1954- Volume(issue)/page/year: 22,618,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
3394 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - ataxia Lungs, Thorax, or Respiration - cyanosis
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University. (Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143, Japan) V.1- 1954- Volume(issue)/page/year: 22,618,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
3698 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University. (Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143, Japan) V.1- 1954- Volume(issue)/page/year: 22,618,1975

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xi

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
S22-S24/25

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
2

[ RTECS ]:
YU7975000

Synthetic Route

Precursor & DownStream

Precursor

  • Adenosine 5′-monophosphate disodium salt
  • D-RIBULOSE 5-PHOSPHATE DISODIUM SALT
  • sodium 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate
  • alpha-d-Ribofuranose, 5-(dihydrogen phosphate) 1-(trihydrogen diphosphate), tetrasodium salt
  • Uridine

DownStream


Related Compounds

  • 5'-UMP disodium salt
  • 5'-Inosinic acid,6-thio-, disodium salt (9CI)
  • 5'-Cytidylic acid, 2'-deoxy-5-Methyl-, disodium salt
  • 5'-Xanthylic acid, 2-S-(2-furanylmethyl)-2-thio-, disodium salt (9CI)
  • 5'-Thymidylic acid
  • 5'-GTP (trisodium salt)
  • 4-{[3,5-dichloro-4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)phenyl]formamido}but-2-ynoic acid
  • (2R)-2-{3-[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)phenyl]prop-2-enamido}butanoic acid
  • 2-[Tert-butyl(methyl)amino]quinazoline-5-carboxylic acid
  • 1-[(2-Chloro-6-fluorophenyl)imino]-3-(methylamino)-1lambda6-thiolan-1-one
  • (1,1-Difluoro-2-methylbut-3-yn-1-yl)benzene
  • rac-[(1R,2R)-2-(2-methylbutan-2-yl)cyclopropyl]methanamine
  • 1-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)oxolane-3-carbonyl]piperidine-2-carboxylic acid
  • 3-{[(1,4-dimethylpiperidin-4-yl)methyl]carbamoyl}-3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoic acid
  • (4R)-3-{2-[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)oxan-3-yl]acetyl}-1,3-thiazolidine-4-carboxylic acid
  • 1-{2-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)ethoxy]acetyl}-5-hydroxypiperidine-3-carboxylic acid
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.